Format

Send to

Choose Destination
J Am Geriatr Soc. 2003 Aug;51(8):1136-42.

Metastatic prostate cancer: complications and treatment.

Author information

1
Geriatrics and Extended Care Service, McGuire VA Medical Center, Richmond, Virginia 23249, USA. cynthia.mcmurtry@med.va.gov

Abstract

Despite highly successful treatments for localized prostate cancer, approximately 35% to 40% of men will eventually experience a detectable rise in serum prostate specific antigen. A portion of these men will go on to experience clinically expressed extracapsular disease, with as many as two-thirds having evidence of bone involvement. Diagnosis of skeletal involvement involves serum markers of disease progression and radiological evaluation. Skeletal-related events are numerous and include bone pain, spinal cord compression, vertebral collapse, and pathological fractures. Current treatments for advanced prostate cancer include individual or combined hormonal therapies, chemotherapy, radiotherapy, surgical treatments, and most recently, antiresorptive medications.

PMID:
12890079
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center